Recommends the Appointment of a Permanent FDA Commissioner
November 18, 2005
Dear Mr. President:
The undersigned organizations represent cancer patients, providers and researchers. We understandably place great value on the work of the Food and Drug Administration (FDA) and National Cancer Institute (NCI). The cancer community depends on NCI to provide leadership and substantial federal funding for basic, translational and clinical cancer research leading to discoveries of new cancer therapies, and on FDA as the efficient gatekeeper for approval and marketing of those products. The absence of permanent qualified leadership at the two agencies is a cause for concern to the more than 1 million patients who are diagnosed with cancer annually and the approximately 12 million people living with cancer in the United States.
We urge you, Mr. President, to make appointment of a permanent FDA Commissioner and permanent NCI Director a priority for your Administration. Every day that these important positions are left in doubt runs the risk that morale at both agencies will suffer and opportunities for advances against cancer will be missed. The governance of both NCI and FDA must be securely in the hands of highly qualified leaders who can devote full and undivided attention to the vital missions entrusted to them.
Cancer Leadership Council
© 2001-2002 Cancer Leadership Council. All rights reserved.